Primary nocturnal enuresis: omega-3 fatty acids may be of therapeutic value

Alan C Logan1, Francois Lesperance

  • 1Nutrition Research Consulting, 50 Yonkers Terrace, 8-J Yonkers, NY 10704, USA. aclnd@cfs-fm.org

Medical Hypotheses
|April 13, 2005
PubMed

Insights

Primary nocturnal enuresis (PNE), or bed-wetting, may be linked to insufficient omega-3 fatty acids. These nutrients are crucial for central nervous system development and may help regulate responses involved in PNE.

Area of Science:

  • Urology
  • Neuroscience
  • Nutritional Science

Background:

  • Primary nocturnal enuresis (PNE) is a common childhood urinary condition.
  • Altered prostaglandin and nitric oxide levels are noted in PNE.
  • PNE is associated with an inappropriate startle response and CNS maturational delay.

Purpose of the Study:

  • To investigate the potential role of omega-3 fatty acids in primary nocturnal enuresis.
  • To explore the link between omega-3s, prostaglandin/nitric oxide production, and CNS function in PNE.

Main Methods:

  • Review of existing research on PNE, prostaglandin/nitric oxide metabolism, and omega-3 fatty acid functions.
  • Hypothesizing the impact of omega-3 intake on PNE pathophysiology.

Main Results:

  • Omega-3 fatty acids can inhibit prostaglandin and nitric oxide production.
  • Omega-3s are vital for central nervous system development and function.
  • Inadequate omega-3 intake may contribute to impaired inhibitory control in PNE.

Conclusions:

  • Omega-3 fatty acids show potential therapeutic value for primary nocturnal enuresis.
  • Further research is warranted to confirm the role of omega-3s in managing PNE symptoms.

Related Concept Videos

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
Urinary Tract Calculi IV: Nutrition Therapy and Prevention01:27

Urinary Tract Calculi IV: Nutrition Therapy and Prevention

Management of renal calculi focuses on effective strategies like tailored nutrition and hydration therapy. Adjusting diet and fluid intake reduces stone formation and recurrence, making these interventions simple yet powerful in kidney stone prevention and management.Understanding Kidney StonesKidney stones form when calcium, oxalate, uric acid, and cystine concentrate and crystallize in urine. Factors contributing to their formation include genetic predisposition, certain medical conditions,...
Urinary Tract Calculi III: Medical Management01:30

Urinary Tract Calculi III: Medical Management

The diagnosis of renal calculi involves several imaging techniques, including non-contrast CT scans and ultrasound. These methods help visualize kidney stones, assess their size and location, and detect possible obstructions. Additionally, Measuring urine pH is useful for diagnosing specific stone types, such as struvite (alkaline pH) and uric acid stones (acidic pH). Cystine stones are primarily linked to cystinuria, a genetic condition. A urinalysis helps detect blood in the urine (hematuria)...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Cholinergic Antagonists: Therapeutic Uses01:26

Cholinergic Antagonists: Therapeutic Uses

Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:    
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal secretions in common...
Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...